Skip to main content
. 2020 Jan 30;59(16):6342–6366. doi: 10.1002/anie.201900585

Figure 17.

Figure 17

A) RhoGEF inhibitors that are highly reactive or contain a PAIN motif (red). Toxicophores of reactive motifs are shown in purple. B) C21, inhibitor of DOCK5, a DHR RhoGEF.